Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Baxter Announces New Data on Benefits of Remote Patient Management for Home Peritoneal Dialysis World Kidney Day 11 March 2021 2021-03-11 16:38
Lianhua Qingwen -- The Leading TCM In Global Anti-Pandemic Programs 2021-03-11 13:46
Ascentage Pharma to Present the Latest Results from Six Preclinical Studies at AACR Annual Meeting 2021 2021-03-11 08:35
OPTEL Group on Track for Record Year in Asia-Pacific Pharma Sales 2021-03-11 04:18
Viva Biotech Successfully Held 2021 Partnership Summit -- Novel Drug 2021, the Persistence and Transformation of Start-up Founders 2021-03-10 20:18
Sihuan Pharmaceutical (0460.HK): Be a friend of time, 2021 is the year of turning point 2021-03-10 15:02
Insilico's Chemistry42 AI system integrated into UCB's drug discovery programs 2021-03-09 22:00
Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021 2021-03-09 16:00
Entire industrial chain resources of advanced medical equipment are lining up at Medtec China 2021 2021-03-09 09:30
FASN Inhibitor ASC40 Demonstrates Positive Phase 2 Topline Clinical Results from China Cohort of Patients with NASH 2021-03-09 08:30
AMD Telemed Applauded by Frost & Sullivan for Its Modular Engage N' Solution that Supports Patient Needs by Acuity Level 2021-03-09 01:12
Wugen Announces Exclusive Partnership Agreement With Alpha Biopharma in Asia For Cell Therapies to Treat Cancer 2021-03-08 22:00
Patients Win When Support Is Personalized: New Study From Atlantis Healthcare Shows Treatment Persistence and Adherence Improved by 38% 2021-03-08 08:48
Cipla Gulf Expands Partnership with Alvotech for Commercialization of Biosimilars in Australia and New Zealand 2021-03-02 22:05
Merck and GPHL Collaborate on Business Innovation and Development in the Greater Bay Area 2021-03-02 18:12
Oscotec and Beactica Therapeutics announce license and collaboration agreement to develop new cancer drug 2021-03-02 15:21
INOVIO Announces Positive Results from REVEAL 1, a Phase 3 Pivotal Trial Evaluating VGX-3100, its DNA-based HPV Immunotherapy for the Treatment of High-grade Precancerous Cervical Dysplasia Caused by HPV-16 and/or HPV-18 2021-03-02 05:05
Everest Medicines Announces Selection as a Constituent of Certain Indexes of Hang Seng Indexes Company Limited 2021-03-01 12:36
Sciwind's Investigational New Drug Approved for NASH Trial 2021-03-01 09:00
Innovent Announces First Patient Outside China Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody 2021-03-01 08:23
1 140 141 142 143 144 242